Heron Therapeutics
Clinical trials sponsored by Heron Therapeutics, explained in plain language.
-
New drug may cut opioid need after hernia surgery
Symptom relief CompletedThis study tested a new pain medicine called HTX 011 in 63 adults having hernia surgery. The goal was to see if it could help control pain and reduce the need for strong opioid painkillers. Participants received the drug during surgery, and researchers tracked how many needed no …
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 30, 2026 15:50 UTC
-
New shot may ease bunionectomy pain, cut opioid need
Symptom relief CompletedThis study tested a new long-acting painkiller called HTX 011 in 412 adults having bunion surgery. The drug was given as a single shot into the surgical site. The goal was to see if it reduces pain and the need for opioid pain pills for three days after surgery, compared to a pla…
Phase: PHASE3 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 29, 2026 15:15 UTC
-
New shot aims to ease pain after bunion surgery
Symptom relief CompletedThis study tested three experimental pain medicines (HTX-011, HTX-002, HTX-009) given locally during bunionectomy to control pain after surgery. 430 adults took part. The main goal was to measure how well they reduced pain over the first 24 hours. This is a phase 2 trial, meaning…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Symptom relief
Last updated Apr 29, 2026 15:05 UTC